Correlation between serum Urocortin-1 and α-Enolase in endometriosis: insights into a potential stress–metabolism signalling axis

Abstract Background Endometriosis affects approximately 10% of women globally, with diagnostic delays often exceeding 8 years. Urocortin-1 (UCN-1) and alpha-enolase (ENO1) have each been independently implicated in its pathobiology, but their co-regulatory relationship in circulation remains poorly understood. This study aimed to quantify serum UCN-1, ENO1, and MMP-9 in patients versus controls, characterise the ENO1–UCN-1 correlation, and evaluate the independent diagnostic contribution of these biomarkers. Results Principal biomarkers were significantly elevated in patients (MMP-9: p = 0.015; ENO1: p = 0.040; UCN-1: p = 0.021). A pivotal finding was the very strong positive correlation between serum ENO1 and UCN-1 ( r = 0.91, 95% CI 0.853–0.945; p < 0.001), suggesting strong co-regulation. Both markers exhibited significant stage-dependent escalation ( p < 0.001). In multivariate logistic regression adjusted for age and BMI, UCN-1 emerged as a strong independent predictor (aOR = 4.564; 95% CI: 1.083–19.227; p = 0.039), while ENO1 was not independently predictive (aOR = 0.868; p = 0.451) due to high collinearity with UCN-1 (VIF = 5.82). The combined panel (UCN-1 + ENO1 + MMP-9) achieved AUC = 0.717 (bootstrap-corrected 0.701; 95% CI 0.611–0.789). Conclusions The r = 0.91 correlation provides preliminary serum-level evidence consistent with a hypothesised stress–metabolism axis, in which UCN-1-mediated signalling may be associated with glycolytic reprogramming (ENO1), putatively via PI3K–Akt and HIF-1α, although the intracellular steps were not measured in this study and the cascade remains hypothesis-generating only. ENO1 is not an independent biomarker of endometriosis in this dataset; its apparent contribution is fully captured by UCN-1 due to strong co-regulation. The combined UCN-1/ENO1/MMP-9 panel is NOT ready for clinical use: the AUC of 0.717 falls well below clinically deployable thresholds (typically AUC ≥ 0.85–0.90), and prospective external validation in larger, multi-centre cohorts — together with direct mechanistic confirmation — is mandatory before any clinical adoption can be considered.

Authors

Institutions

Publication Details

Journal
Middle East Fertility Society Journal
Published
2026-11-14
DOI
https://doi.org/10.1186/s43043-026-00338-w
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Correlation between serum Urocortin-1 and α-Enolase in endometriosis: insights into a potential stress–metabolism signalling axis

Suhaila Fadhil Al-Shaikh, Khawla A. Shemran, Zainab Basil Jabbar
Middle East Fertility Society Journal
Endometriosis Research and Treatment
article

Correlation between serum Urocortin-1 and α-Enolase in endometriosis: insights into a potential stress–metabolism signalling axis

Suhaila Fadhil Al-Shaikh, Khawla A. Shemran, Zainab Basil Jabbar
article en

Abstract

Abstract Background Endometriosis affects approximately 10% of women globally, with diagnostic delays often exceeding 8 years. Urocortin-1 (UCN-1) and alpha-enolase (ENO1) have each been independently implicated in its pathobiology, but their co-regulatory relationship in circulation remains poorly understood. This study aimed to quantify serum UCN-1, ENO1, and MMP-9 in patients versus controls, characterise the ENO1–UCN-1 correlation, and evaluate the independent diagnostic contribution of these biomarkers. Results Principal biomarkers were significantly elevated in patients (MMP-9: p = 0.015; ENO1: p = 0.040; UCN-1: p = 0.021). A pivotal finding was the very strong positive correlation between serum ENO1 and UCN-1 ( r = 0.91, 95% CI 0.853–0.945; p < 0.001), suggesting strong co-regulation. Both markers exhibited significant stage-dependent escalation ( p < 0.001). In multivariate logistic regression adjusted for age and BMI, UCN-1 emerged as a strong independent predictor (aOR = 4.564; 95% CI: 1.083–19.227; p = 0.039), while ENO1 was not independently predictive (aOR = 0.868; p = 0.451) due to high collinearity with UCN-1 (VIF = 5.82). The combined panel (UCN-1 + ENO1 + MMP-9) achieved AUC = 0.717 (bootstrap-corrected 0.701; 95% CI 0.611–0.789). Conclusions The r = 0.91 correlation provides preliminary serum-level evidence consistent with a hypothesised stress–metabolism axis, in which UCN-1-mediated signalling may be associated with glycolytic reprogramming (ENO1), putatively via PI3K–Akt and HIF-1α, although the intracellular steps were not measured in this study and the cascade remains hypothesis-generating only. ENO1 is not an independent biomarker of endometriosis in this dataset; its apparent contribution is fully captured by UCN-1 due to strong co-regulation. The combined UCN-1/ENO1/MMP-9 panel is NOT ready for clinical use: the AUC of 0.717 falls well below clinically deployable thresholds (typically AUC ≥ 0.85–0.90), and prospective external validation in larger, multi-centre cohorts — together with direct mechanistic confirmation — is mandatory before any clinical adoption can be considered.

Middle East Fertility Society JournalVol. 31(1)
University of Babylon (IQ)
Good health and well-being
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon